M.E. Allison & Co’s Pfizer PFE Stock Holding History

M.E. Allison & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	41,742 +2,112	+5%	+$55.2K	0.58%	45
2026 Q1	$1.11M	Buy	39,630 +1,956	+5%	+$52.1K	0.74%	36
2025 Q4	$938K	Buy	37,674 +1,162	+3%	+$29.3K	0.64%	44
2025 Q3	$930K	Buy	36,512 +164	+0.5%	+$4.05K	0.65%	43
2025 Q2	$881K	Buy	36,348 +11,186	+44%	+$261K	0.71%	39
2025 Q1	$638K	Buy	25,162 +8,851	+54%	+$232K	0.63%	44
2024 Q4	$247K	Buy	+16,311	New	+$442K	0.27%	114

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

M.E. Allison & Co's PFE Position: Q2 2026 in Review

M.E. Allison & Co increased its Pfizer (PFE) stake by 5.3% in Q2 2026, buying an estimated $55.2K and bringing the position to 41,742 shares worth $1.01M. The position accounts for 0.58% of the portfolio, ranked #45.

M.E. Allison & Co first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

M.E. Allison & Co held 41,742 shares of Pfizer worth $1.01M as of Q2 2026.
M.E. Allison & Co bought 2,112 Pfizer shares in Q2 2026, an estimated $55.2K.
Pfizer made up 0.58% of M.E. Allison & Co's portfolio in Q2 2026, its #45 holding.
M.E. Allison & Co first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
M.E. Allison & Co's Pfizer position peaked at $1.11M in Q1 2026.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on M.E. Allison & Co's 13F filing for Q2 2026, filed 7 Jul 2026.